SWP
RMD icon

Sagespring Wealth Partners’s ResMed RMD Stock Holding History

Sagespring Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Sell
1,878
-325
-15% -$67.4K 0.01% 617
2026
Q1 		$494K Sell
2,203
-66
-3% -$16.4K 0.01% 500
2025
Q4 		$546K Buy
2,269
+243
+12% +$62.1K 0.01% 451
2025
Q3 		$554K Buy
2,026
+69
+4% +$18.8K 0.01% 438
2025
Q2 		$505K Buy
1,957
+407
+26% +$97.1K 0.01% 438
2025
Q1 		$347K Buy
1,550
+19
+1% +$4.44K 0.01% 472
2024
Q4 		$350K Buy
+1,531
New +$369K 0.01% 432

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Sagespring Wealth Partners's RMD Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its ResMed (RMD) stake by 15% in Q2 2026, selling an estimated $67.4K and leaving 1,878 shares worth $366K. The position accounts for 0.01% of the portfolio, ranked #617.

Sagespring Wealth Partners first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $554K in Q3 2025. 494 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Sagespring Wealth Partners held 1,878 shares of ResMed worth $366K as of Q2 2026.
  • Sagespring Wealth Partners sold 325 ResMed shares in Q2 2026, an estimated $67.4K.
  • ResMed made up 0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #617 holding.
  • Sagespring Wealth Partners first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Sagespring Wealth Partners's ResMed position peaked at $554K in Q3 2025.
  • 494 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.